Bee Vectoring Technologies International Inc.

Recent News

• Bee Vectoring Technologies to Host Live Corporate Webinar on March 23rd at 1pm ET

  Ashish Malik, CEO, will provide a corporate overview via a live presentation followed by live Q&AInvestors and other interested parties are invited to join and learn more about Bee Vectoring's patented crop-control systemMississauga, Ontario and Sacramento, California--(Newsfile Corp. - March 16, 2023) - Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE: BEE) (the "Company" or "BVT") is pleased to announce that the Company's CEO, Ashish Malik, will be presenting BVT's most recent investor presentation, including an overview of current operations,...

  2023-03-16 8:00 AM EDT
• Bee Vectoring Technologies Announces a Second Year of Successful Seed Treatment Trial Results

  Consistently increased crop yields and outperformed base seed treatmentLarger, healthier soybean plants; more biomass and higher plant vigorConsistent, repeating positive results to add to successful first year trialsMississauga, Ontario and Sacramento, California--(Newsfile Corp. - March 7, 2023) - Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE: BEE) (the "Company" or "BVT") is pleased to announce positive second year trial results demonstrating the efficacy of BVT's proprietary biological control agent Clonostachys rosea strain CR-7 (CR-7) as a seed...

  2023-03-07 8:00 AM EST
• Bee Vectoring Technologies Closes Non-Brokered Private Placement and Debt Settlement

  Mississauga, Ontario and Sacramento, California--(Newsfile Corp. - March 6, 2023) - Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE: BEE) (the "Company" or "BVT") is pleased to announce that it has closed a non-brokered private placement of 1,491,667 units (the "Units") issued at a price of $0.12 per Unit for gross aggregate proceeds of $179,000 (the "Private Placement"). Each Unit is comprised of one common share (each a "Share") and one common share purchase warrant (each a "Warrant")....

  2023-03-06 4:44 PM EST
• Bee Vectoring Technologies Announces Rutgers University's Year 2 Positive Trial Results: Reduced Fungal Disease and Better Bee Health

  Mississauga, Ontario and Sacramento, California--(Newsfile Corp. - February 22, 2023) - Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE: BEE) (the "Company" or "BVT") is pleased to announce Rutgers University has successfully completed year 2 research trials on the efficacy of BVT's proprietary Vectorite with CR-7 (Clonostachys rosea CR-7), applied with bee vectoring technology to New Jersey blueberry crops during the 2022 growing season. Furthermore, the bee colony health was also assessed in year 2.Both year 1 and year 2 trials...

  2023-02-22 8:00 AM EST
• Bee Vectoring Technologies Announces Fiscal Year 2022 Financial Results and 2023 Business Outlook

  Mississauga, Ontario and Sacramento, California--(Newsfile Corp. - January 31, 2023) - Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE: BEE) (the "Company" or "BVT") today released a letter to shareholders from Chief Executive Officer Ashish Malik announcing the financial results for the fourth quarter and fiscal year ended September 30, 2022. The financial statements and MD&A are available on the Company's website at www.beevt.com and on SEDAR at www.sedar.com.The shareholder letter is as follows:Dear Shareholders,It is with pleasure that I present...

  2023-01-31 8:00 AM EST
• Bee Vectoring Technologies Successfully Secures First Blueberry Customer in California; Customer Further Agrees to Cherry Trial

  Mississauga, Ontario and Sacramento, California--(Newsfile Corp. - January 24, 2023) - Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE: BEE) (the "Company" or "BVT") is pleased to announce its first blueberry order in California. The Fresno-based customer will be using BVT's proprietary Vectorite with CR-7 (Clonostachys rosea CR-7) biological fungicide and natural precision agriculture system on their blueberry crops and has also committed to a demonstration trial on their cherry orchards."This order is another clear demonstration that our strong customer base...

  2023-01-24 8:00 AM EST
• Bee Vectoring Technologies Announces Commercial Agreement with BioSafe Systems to Sell CR-7 Products into Foliar and Soil Drench Markets

  Mississauga, Ontario and Sacramento, California--(Newsfile Corp. - January 10, 2023) - Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE: BEE) (the "Company" or "BVT") and BioSafe Systems jointly announced a signed commercial agreement. BioSafe Systems, an industry leader in environmentally sustainable products, will offer a range of products based on BVT's Clonostachys rosea CR-7 (CR-7) proprietary microbe for use in foliar and soil drench markets in the United States, with future options to expand into Mexico and other countries."This partnership...

  2023-01-10 8:00 AM EST
• Bee Vectoring Technologies Announces Addition of Ashish Malik to its Board of Directors

  Mississauga, Ontario and Sacramento, California--(Newsfile Corp. - December 23, 2022) - Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE: BEE) (the "Company" or "BVT") is pleased to announce the appointment of Ashish Malik to the Company's board of directors.Mr. Malik is currently the Chief Executive Officer and President of BVT. He was previously the VP of Global Marketing for Biologics at Bayer CropScience. He was responsible for managing the portfolio of biological assets for the Company and advancing...

  2022-12-23 8:00 AM EST
• Bee Vectoring Technologies Announces Further Geographic Expansion with Official Submission for Regulatory Approval in Canada

  Mississauga, Ontario and Sacramento, California--(Newsfile Corp. - December 8, 2022) - Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE: BEE) (the "Company" or "BVT") is pleased to announce that the Company's proprietary Clonostachys rosea CR-7 (CR-7) biological fungicide has been submitted for regulatory review and approval in Canada. The submitted dossier includes CR-7 trial data already successfully completed, as well as studies into human safety, environmental impact, product efficacy and more, as required."Canadian growers face the same disease pressure as those...

  2022-12-08 8:00 AM EST
• Bee Vectoring Technologies Partners with Agri Spray Drones for Targeted Application in Mega-Crops

  Mississauga, Ontario and Sacramento, California--(Newsfile Corp. - October 25, 2022) - Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE: BEE) (the "Company" or "BVT") is pleased to announce a new partnership with Missouri-based Agri Spray Drones, a leading-edge provider of end-to-end agricultural drone solutions. Together, they will trial drone application of BVT's proprietary Clonostachys rosea CR-7 (CR-7) biological fungicide on large-acre crops such as soybeans, corn, alfalfa and canola."BVT has been primarily focused on delivering CR-7 via commercially-managed bees," said Ashish...

  2022-10-25 8:00 AM EDT